JP2932400B2 - Livestock urolithiasis preventive and remedy - Google Patents
Livestock urolithiasis preventive and remedyInfo
- Publication number
- JP2932400B2 JP2932400B2 JP2330571A JP33057190A JP2932400B2 JP 2932400 B2 JP2932400 B2 JP 2932400B2 JP 2330571 A JP2330571 A JP 2330571A JP 33057190 A JP33057190 A JP 33057190A JP 2932400 B2 JP2932400 B2 JP 2932400B2
- Authority
- JP
- Japan
- Prior art keywords
- urolithiasis
- preventive
- extract
- ammonium chloride
- livestock
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【発明の詳細な説明】 (産業上の利用分野) 本発明は家畜用尿石症の予防治療剤に関する。Description: TECHNICAL FIELD The present invention relates to a preventive and therapeutic agent for veterinary urolithiasis.
(従来の技術) 肥育牛での尿石症の発生は昭和29年からすでに散見さ
れており、昭和40年代から多発するようになった。(Conventional technology) The occurrence of urolithiasis in fattening cattle has been seen sporadically since 1954, and has become frequent since the 1970s.
その原因としては、飼育管理の省力化、濃厚飼料の多
給が考えられ、一般に粗飼料が不足し飲水量が少なくな
る冬期に多発する。尿石症は通常、雄去勢牛の18〜30ヵ
月齢の肥育末期に多発するとされていたが、近年は4〜
6ヶ月齢の若齢牛での発生も多く、尿石症の発生に月齢
差はなくなってきている。The possible causes are labor saving in breeding management and intensive feeding of concentrated feed. In general, it occurs frequently in winter when roughage is insufficient and water consumption is reduced. Urolithiasis was usually reported to occur frequently at the end of fattening in steers of 18-30 months of age in bulls.
The incidence of 6-month-old young cows is high, and the age difference in urolithiasis has disappeared.
その治療法としては、塩化アンモニウムを単独である
いはビタミンA、ビタミンD3との混合剤を投与する方法
が実用化されているが、結石の性状や組成によりその効
果にはバラツキがある。As the treatment method, alone or vitamin A and ammonium chloride, a method of administering the admixture of vitamin D 3 has been put into practical use, there is a variation in the effect by nature and composition of stones.
また、外科手術による結石の除去は、生産性の低下に
つながり、また再発の可能性が高く、適当な治療方法と
は言えない。肥育農家が国際的な競争力を培うため、生
産性や肉質の向上をめざし、安定した経営を営むうえで
尿石症の治療予防法の確立が急務となっている。In addition, removal of a calculus by a surgical operation leads to a decrease in productivity and a high possibility of recurrence, which is not a suitable treatment method. There is an urgent need for fattening farmers to establish a treatment and prevention method for urolithiasis in order to cultivate international competitiveness, improve productivity and meat quality, and run a stable business.
更に肥育牛の他に乳牛、豚、犬、猫等においても同様
な問題が生じている。Further, similar problems occur in dairy cows, pigs, dogs, cats, etc. in addition to fattening cows.
(発明が解決しようとする課題) 本発明の目的は、塩化アンモニウム剤やビタミンA、
ビタミンD3との混合剤や外科手術に関する前記の問題点
を解決し、より有効な家畜用尿石症予防治療剤を提供す
ることにある。(Problems to be solved by the invention) An object of the present invention is to provide an ammonium chloride agent, vitamin A,
The problems solved regarding admixtures or surgery and vitamin D 3, to provide a more effective veterinary urolithiasis preventing or treating agent.
(課題を解決するための手段) 本発明は塩化アンモニウムとウラジロガシエキスを主
成分とする家畜用尿石症予防治療剤である。(Means for Solving the Problems) The present invention is a preventive and therapeutic agent for veterinary urolithiasis, which comprises ammonium chloride and urajirogashi extract as main components.
肥育牛における尿石症は濃厚飼料の多給、飼料中カル
シウム対リン比の低下などにより、腎臓、膀胱などで結
石が形成され、それらが流出する過程で尿道に滞留する
ことにより、排尿が困難になり食欲不振、元気消失など
の症状を呈し、尿毒症により死亡ないし廃用に至る。そ
の発見は、陰毛部への結石の付着、乾燥あるいは炎症の
有無などにより行う。Urolithiasis in fattening cattle is difficult to urinate because calculi are formed in the kidneys and bladder due to high feeding of concentrated feed and a decrease in the calcium-to-phosphorus ratio in the feed, and they remain in the urethra as they flow out. Symptoms such as loss of appetite and loss of energy, and death or disuse due to uremia. The discovery is based on the adhesion of calculus to the pubic hair, the presence of dryness or inflammation, and the like.
本発明における塩化アンモニウムとウラジロガシエキ
スの混合剤は、この他に食塩、ビタミンA、ビタミン
D3、カルシウムや種々の利尿剤を含むことができる。本
発明における混合剤は、粉剤、散剤、粒剤、錠剤などを
使用場面に応じて種々の剤形をとり、それらを直接ある
いは飲水または飼料に混和して投与するとよい。In the present invention, the mixture of ammonium chloride and Virginia oak extract may further include salt, vitamin A, vitamin
It can contain D 3 , calcium and various diuretics. The mixture in the present invention may be in the form of powders, powders, granules, tablets or the like in various dosage forms depending on the use, and these may be administered directly or mixed with drinking water or feed.
治療剤として用いる場合は、前記の症状を呈する初中
期あるいは後期までに1日1頭あたり塩化アンモニウム
として1〜100g、ウラジロガシエキスとして1〜100gの
投与量となるように混合剤を1〜10日間投与する。更に
は1日1頭あたり塩化アンモニウムとして10〜50g、ウ
ラジロガシエキスとして2〜30gの投与量となるように
混合剤を投与するのが好ましい。また、予防剤として用
いる場合は、1頭でも尿石症の診断をされたりその症状
を呈した場合はその群に多発の可能性があるので、1日
1頭あたり塩化アンモニウムとして0.5〜20g、ウラジロ
ガシエキスとして0.1〜10gの混合剤を継続的に投与す
る。更には1日1頭あたり塩化アンモニウムとして4〜
10g、ウラジロガシエキスとして0.2〜5gの投与量となる
ように混合剤を投与するのが好ましい。When used as a therapeutic agent, the mixture is administered for 1 to 10 days as 1 to 100 g of ammonium chloride per day and 1 to 100 g of urajirogashi extract per head by the first or middle stage showing the above-mentioned symptoms. Administer. Further, it is preferable to administer the mixture so that the dosage is 10 to 50 g as ammonium chloride and 2 to 30 g as urajirogashi extract per animal per day. In addition, when used as a prophylactic agent, even if one animal is diagnosed with urolithiasis or presents its symptoms, there is a possibility of multiple occurrence in the group, so 0.5 to 20 g of ammonium chloride per animal per day, Continuously administer 0.1 to 10 g of the mixture as Vladivostalis extract. Furthermore, it is 4 ~
It is preferable to administer the mixture so as to give a dose of 10 g, 0.2 to 5 g as a vulgaris extract.
参考例 ウラジロガシエキスの製法 ウラジロガシの乾燥した小枝付葉を粗切し、水を加え
て浸出後、浸出液を濾禍し、濾液を減圧濃縮後噴務乾燥
し、粉末エキスとする。REFERENCE EXAMPLE Preparation of Vulgaris extract Extract of dried twigs of Vulvulcus is roughly cut off, leached by adding water, the leachate is filtered, and the filtrate is concentrated under reduced pressure and dried by spraying to obtain a powder extract.
製剤例 塩化アンモニウム 40g ウラジロガシエキス 20g スターチ 40g を混合し100gの粉剤とする。Formulation example Ammonium chloride 40 g Virgin oak extract 20 g Starch 40 g are mixed to make 100 g of powder.
実施例 肥育牛を常時500頭飼育している農家で尿石症と診断
された牛30頭を供試した。Example 30 cattle diagnosed with urolithiasis were tested in a farmer who constantly raised 500 fattening cattle.
体重、症状により群間で差がないよう3群に分け、そ
れぞれに塩化アンモニウム40%製剤(本投与群を以下A
区分とする)、ウラジロガシエキス50%製剤(本投与群
を以下U区分とする)あるいは前記製剤例にて調製した
塩化アンモニウム:ウラジロガシエキス混合剤(本投与
群を以下AU区分とする)を体重に合わせて規定量を水に
溶かして5日間強制投与した。陰毛部の結石付着、炎症
および排尿行動などを観察し、効果の判定を行い、完全
に正常になったものを治癒、何らかの改善が認められた
ものを有効とし、その結果を第1表に示す。The rats were divided into three groups so that there was no difference between the groups according to body weight and symptoms.
), 50% Vuliragashi extract (this administration group is hereinafter referred to as U category) or the ammonium chloride: Viragiga extract mixture prepared in the above formulation example (this administration group is hereafter AU category). The specified amount was dissolved in water and gavaged for 5 days. Observation of calculus adhesion, inflammation and urinating behavior of the pubic hair, etc., judgment of the effect, healing of those who became completely normal, those of some improvement were regarded as effective, and the results are shown in Table 1. .
投与3日後にA区分で1頭、U区分で4頭、AU区分で
8頭治癒し、又それぞれの区分で2、1、2頭が有効で
あった。また、投与終了時(投与5日目)にはそれぞれ
の区分で2、5、9頭が治癒し、各1頭ずつ有効であっ
た。更に、投与終了後1週間目にはそれぞれの区分で
3、6、10頭が治癒した。Three days after administration, 1 animal in Category A, 4 animals in Category U, and 8 animals in Category AU were cured, and 2, 1, and 2 animals were effective in each category. At the end of the administration (day 5 of administration), 2, 5, and 9 animals were cured in each category, and one animal each was effective. One week after the end of the administration, 3, 6, and 10 animals healed in each category.
なお、投与量及びその有効成分量を第2表に示す。 Table 2 shows the dose and the amount of the active ingredient.
(発明の効果) 本発明の塩化アンモニウムとウラジロガシエキスの混
合剤は牛の尿石症の治療に卓抜した効果を示した。 (Effect of the Invention) The mixture of ammonium chloride and Virginia oak extract of the present invention showed a remarkable effect in the treatment of urolithiasis in cattle.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.6,DB名) A61K 35/78 A61K 33/02 CA(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Fields surveyed (Int. Cl. 6 , DB name) A61K 35/78 A61K 33/02 CA (STN)
Claims (1)
を主成分とする家畜用尿石症予防治療剤。1. A preventive and therapeutic agent for urolithiasis for veterinary animals, comprising ammonium chloride and Virginia vulgaris extract as main components.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2330571A JP2932400B2 (en) | 1990-11-30 | 1990-11-30 | Livestock urolithiasis preventive and remedy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2330571A JP2932400B2 (en) | 1990-11-30 | 1990-11-30 | Livestock urolithiasis preventive and remedy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH04208227A JPH04208227A (en) | 1992-07-29 |
| JP2932400B2 true JP2932400B2 (en) | 1999-08-09 |
Family
ID=18234143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2330571A Expired - Fee Related JP2932400B2 (en) | 1990-11-30 | 1990-11-30 | Livestock urolithiasis preventive and remedy |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2932400B2 (en) |
-
1990
- 1990-11-30 JP JP2330571A patent/JP2932400B2/en not_active Expired - Fee Related
Non-Patent Citations (3)
| Title |
|---|
| Chemical Abstracts,Vol.68,要約番号 67781 |
| Chemical Abstracts,Vol.73,要約番号 63760 |
| Chemical Abstracts,Vol.76,要約番号 98185 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH04208227A (en) | 1992-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MacAllister et al. | Effects of omeprazole paste on healing of spontaneous gastric ulcers in horses and foals: a field trial | |
| EA017656B1 (en) | Composition for prevention and treatment of pig dysentery | |
| EP2724724B1 (en) | Treatment and prevention of epithelial infections with copper and zinc chelates | |
| JPH0387150A (en) | Method for avoiding indigestion of herbivorous animal | |
| US7067161B2 (en) | Animal food supplement compositions and methods of use | |
| AU608672B2 (en) | Method for treating hoof thrush and hoof rot | |
| JP2932400B2 (en) | Livestock urolithiasis preventive and remedy | |
| Redmond et al. | The effect of phenothiazine and withdrawal time on gravid mares grazing endophyte-infected tall fescue | |
| WO2000048613A1 (en) | Method of treatment of equine disease | |
| DE69906335T2 (en) | ANIMAL BEHAVIOR | |
| Drennan et al. | Single-Suckled Beef Production: 3. Effect of Plane of Nutrition during Late Pregnancy on Cow Performance | |
| US20150306062A1 (en) | Treatment and prevention of epithelial infections | |
| DE10251753A1 (en) | Treatment of inflammation and/or pain in animals, especially joint inflammation and/or pain in horses, by administration of ginger, preferably as feed additive | |
| JP2926352B2 (en) | How to treat cows with no or no estrus | |
| EP3310351B1 (en) | Oral use of zinc- and copper gluconates in the treatment of digital dermatitis | |
| Sawyer et al. | Growth response of steer calves treated with zeranol, oestradiol 17β or progesterone‐oestradiol benzoate implants before and after weaning | |
| Hogan et al. | Ration of sow and response of suckling pigs | |
| JPH10226643A (en) | Livestock preventive and therapeutic agents | |
| Holste | Productivity studies with ivermectin in beef cattle | |
| Van der Vyver, FH,* Kellerman, TS,* Bastianello, Stella S.,* De Wet, JAL,** Joubert, JPJ*** & Faul | Valsiekte (Falling disease): a nervous disorder in lambs suspected of being caused by the plant Chrysocoma tenuifolia | |
| Akusu | The effect of plane of nutrition on vital reproduction statistics of West African Dwarf (WAD) goats. | |
| Shellenberger et al. | Effectiveness of a combination of antibiotics in a bolus and of potassium levopropylcillin in the prevention of pasture bloat | |
| Haggard et al. | Footrot of cattle | |
| Shearer | Hoof health: a critical factor in animal performance. | |
| Lamb | Synchronization of Estrous in recipients using CIDRs and GnRH |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |